IN8bio, Inc.INABNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +50.01% | +58.30% | +92.86% | -90.87% | -90.41% |
| Weighted Average Shares Diluted Growth | +50.01% | +58.30% | +92.86% | -90.87% | -90.41% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -39.08% | -37.87% | -22.23% | -13.89% | +5.02% |
| Book Value per Share Growth | -67.76% | -63.32% | -58.94% | +1125.65% | +1501.56% |
| Debt Growth | +3.99% | +2.80% | -25.25% | -47.13% | -45.96% |
| R&D Expense Growth | -12.60% | -20.52% | -39.38% | -51.76% | -36.42% |
| SG&A Expenses Growth | -19.24% | -14.50% | -28.17% | -23.18% | -31.81% |